Surge in Operating EBITDA and International Patient Revenue Growth

In a remarkable financial performance, Operating EBITDA soared by 23% to reach Rs 613 crore, demonstrating robust margins at 24.9%. Additionally, international patient revenue experienced a significant rise of 32%, totaling Rs 208 crore and accounting for 9% of overall hospital revenue.

Financial Performance Overview

The recent financial report showcases impressive growth metrics that signal strong operational health and strategic success. Here’s a closer look at the highlights:

Operating EBITDA Growth

• Increase: Operating EBITDA rose by 23%.
• Current Value: Stands at Rs 613 crore.
• Margins: Maintained a healthy margin of 24.9%.

This substantial growth in EBITDA indicates effective cost management and enhanced operational efficiencies, contributing significantly to the bottom line.

Surge in International Patient Revenue

• Growth Rate: International patient revenue saw a 32% growth.
• Total Revenue: Reached approximately Rs 208 crore.
• Contribution: Represents around 9% of total hospital revenue.

The increase in international patient revenue reflects the hospital's expanding global reach and attractiveness to foreign patients seeking medical services. This segment's growth not only diversifies the revenue streams but also showcases the hospital's commitment to quality care, resulting in higher patient acquisition from international markets.

Conclusion

The operational metrics demonstrate a thriving hospital sector with robust financial health. The combined growth in both operating EBITDA and international patient revenue highlights the effectiveness of current strategies and positions the hospital favorably for continued future growth, ensuring sustainability and profitability in a competitive market.